SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Renovo Plc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: nigel bates8/29/2007 7:18:05 AM
  Read Replies (1) of 40
 
Renovo Group plc Issue of Equity

Pursuant to the announcement made on 17 August 2007, the Company announces that
it has today issued 12,378,689 new ordinary shares of 10p each ('New Ordinary
Shares') at a price of 200p per share raising £24,757,378 before expenses (the '
Placing'). The New Ordinary Shares have been admitted to trading on the
Official List of the London Stock Exchange ('Admission') and dealings commenced
today.

As a result of the issue of the New Ordinary Shares, the issued share capital
now £18,954,898.50 comprises 189,548,985 ordinary shares of 10p each.

The total number of voting rights as at 20 August 2007 is 189,548,985. There
are no shares in treasury and there is no other class of share in issue which
has voting rights. This figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in the Company, under the FSA's
Disclosure and Transparency Rules...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext